SUPPLEMENTAL TABLES.docx (46.19 kB)
Download file

Supplementary Tables – A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer

Download (46.19 kB)
dataset
posted on 25.05.2022, 08:48 by Figshare Future Science GroupFigshare Future Science Group, Kristin M Sheffield, Jessica R Peachey, Michael Method, Brenda R Grimes, Jacqueline Brown, Kim Saverno, Tomoko Sugihara, Zhanglin Lin Cui, Kimberley T Lee

  

Table S1. Hazard Ratios from Multivariable Cox Proportional Hazards Regression Models Comparing High-risk Group with Node Negative Group (n=3424)

 

Table S2. Hazard Ratios from Multivariable Cox Proportional Hazards Regression Models for US FDA-approved Indicated Patient Subgroup Compared with Non-high-risk Group (n=3607)  

  

Table S3. Hazard Ratios for IDFS from Two Independent Cox Proportional Hazards Regression Models for Two Different Time Periods (High-risk vs. Non-high-risk is Comparison of Interest)

  

Table S4. Hazard Ratios for IDFS from Two Independent Cox Proportional Hazards Regression Models for Two Different Time Periods (High-risk vs. Non-high-risk is Comparison of Interest)


Funding

Eli Lilly and Company, IN, USA

History